ArticleJournal of family medicine and primary care2022
Assessment of the efficacy of hearing screening program in infants in Zahedan.
Article in Journal of family medicine and primary care, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 2 citations in OpenAlex.
- Situational analysis of health systems for ear and hearing care in the World Health Organization (WHO) Eastern Mediterranean Region: A systematic review and evidence synthesis to inform national policies and strategies.SSM - health systems · 2026Article
- A survey of strategies for the early diagnosis of hearing loss in infants: a scoping review.CoDAS · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Hearing loss is one of the major congenital problems. The frequency of this problem in different countries has been found to be 3.5-9%, which may induce negative effects on communications, education, and language learning in children. In addition, diagnosing this problem in infants is not possible without implementing the hearing screening methods. Therefore, the objective of this research was to assess the efficacy of newborn hearing screening programs in Zahedan, Iran. Method: In the present cross-sectional observational study, all infants born in the maternity hospitals of Zahedan city (hospitals of Nabi Akram, Imam Ali, and Social Security hospitals) in 2020, were assessed. For conducting the research, TEOAE was primarily performed for all newborns. Following that, according to the findings obtained in the ODA test and in case of inappropriate response, evaluation was performed again for the cases. Cases that were rejected again in the second assessment were subjected to the AABR test and in case of failure in this test, the cases underwent a diagnostic ABR test. Results: According to our findings, 7700 babies were initially assessed with the OAE test. Among them, 580 (8%) showed no OAE response. Out of 580 newborns that were rejected in the first phase, 76 babies were also rejected in the second phase and amongst them, 8 cases were re-diagnosed with hearing loss. Finally, out of 3 infants who were diagnosed with hearing impairments, 1 (33%) had conductive hearing loss and 2 (67%) had sensorineural hearing loss. Conclusion: According to the results of this research, the use of comprehensive neonatal hearing screening programs is necessary for on-time diagnosis and therapy of hearing loss. In addition, screening programs could help improving the health of newborns and their personal, social, and educational development in the future.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.